Endovascular thromBectomy of Acute Mesentery Vessels Occlusion Hybrid With Emergent Laparoscopic Surgery
BOWEL
Vascular Surgery Department of Beijing Tsinghua Chang Gung Hospital
1 other identifier
observational
42
1 country
1
Brief Summary
Acute mesenteric artery thromboembolism(AMT) is one of the important causes of acute abdomen and intestinal necrosis. If the intestinal blood supply is not restore in time, the prognosis of the disease is often poor and even endangers the life of the patient. Through laparoscopic surgery combined with modern minimally invasive endovascular technology, the blood supply of patients' intestine is restored. Observe the perioperative vascular patency rate, all-cause mortality, and the probability of short bowel syndrome. Through the hybrid operating room, we want to seek a multidisciplinary collaborative treatment mode to improve the long-term survival rate of such patients with enough intestines and completely free from TPN, and improve the prognosis of these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
December 16, 2020
CompletedFirst Posted
Study publicly available on registry
December 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedMarch 21, 2024
March 1, 2024
2.7 years
December 16, 2020
March 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
survival rate with preserved bowel function
Counting data
within 30 days after operations
Secondary Outcomes (2)
the incidence of all-cause mortality
within 30 days after operations
vascular patency rate
180 days after operations
Study Arms (1)
mesenteric artery thromboembolism patients
If all the radiography, physical signs, and laboratory markers hint at intestinal necrosis, exploratory laparotomy followed by enterectomy and thrombectomy is the first choice. If none of them hint at intestinal necrosis, endovascular therapy is superior. Laparoscopic exploration followed by endovascular therapy was performed for other patients, after that the intestinal blood supply was evaluated again by laparoscopy.
Eligibility Criteria
the patients suffering from superior mesenteric artery thromboembolism
You may qualify if:
- Patients with intestinal ischemia and acute abdomen pain caused by superior mesenteric artery thromboembolism
You may not qualify if:
- Those who have acute large-area myocardial infarction, large-area cerebral infarction, or have serious heart failure or sequelae of cerebral infarction within 1 month;
- Combined with portal hypertension, gastrointestinal hemorrhage, portal and mesenteric venous reflux obstruction diseases;
- Contrast agent allergy, severe renal insufficiency, and inability to perform intravascular surgery;
- Past medical history contains superior mesenteric artery thromboembolism.
- Patients diagnosed with intestinal necrosis and peritonitis before surgery based on physical signs and imaging studies who directly undergo laparotomy and incision for thrombectomy.
- Patients without intestinal necrosis or peritonitis based on physical signs and imaging studies, who are treated by endovascular intervention therapy directly.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Tsinghua Chang Gung Hosipital
Beijing, Beijing Municipality, 102218, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
sifan yang
Beijing Tsinghua Chang Gung Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department director
Study Record Dates
First Submitted
December 16, 2020
First Posted
December 29, 2020
Study Start
October 1, 2020
Primary Completion
June 1, 2023
Study Completion
July 1, 2023
Last Updated
March 21, 2024
Record last verified: 2024-03